China plans more support for pharma innovation

China will speed up approvals for innovative drugs and medical devices as it seeks to boost pharmaceutical innovation. The country has approved 59 innovative drugs and 51 innovative medical devices so far this year, a drug regulatory official said Sunday.

September 21, 2026

SAMR looks to shift business focus from 'low-price rivalry' to quality, efficiency

China will make greater use of standards, price enforcement, and quality supervision to curb "involution-style" competition, steering businesses toward improving quality and efficiency, rather than engaging in excessive low-price rivalry, the country's top market regulator said on Sunday.

September 21, 2026